CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	6 Months Ended		12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2013
Cash flows from operating activities
Net loss	$ (670,683)	$ (4,347,353)	$ (5,489,892)
Adjustments to reconcile net loss to net cash used in operating activities:
Provision for doubtful accounts	(50,036)	(44,716)
Provision for employee advance reserve	4,715
Depreciation and amortization	83,887	71,693
Stock-based compensation	268,263	353,407
Warrants issued to 2012 private placement investors		487,200
Loss on extinguishment of notes and accounts payable		2,792,900
Imputed value of services contributed	116,667	175,000
Amortization of debt discount	117,901	84,763
Changes in operating assets and liabilities:
Accounts receivable	269,361	(73,928)
Inventories - finished goods	105,634	37,987
Prepaid expenses and other current assets	29,160	(815)
Accounts payable - trade	(329,826)	(205,364)
Accounts payable - related parties	(35,017)	159,050
Accrued expenses and other current liabilities	69,104	(360,175)
Deferred revenue	(58,306)	(55,182)
Net cash used in operating activities	(79,176)	(925,533)	(1,024,781)
Cash flows from investing activities
Change in restricted cash		850,002
Website development costs	(67,785)	(51,796)
Net cash (used in) and provided by investing activities	(67,785)	798,206
Cash flows from financing activities
Principal payments on equipment leases payable	(27,000)	(23,838)
Proceeds from issuance of notes payable	150,000	500,000
Repayment of notes payable		(2,000,000)
Repayment of convertible notes payable		(1,000,000)
Proceeds from the sale of common stock		2,651,973
Net cash provided by financing activities	123,000	128,135
(Net decrease) net increase in cash	(23,961)	808
Cash - beginning of period	67,744
Cash - end of period	43,783	808	67,744
Interest	44,362	399,374
Taxes	89	899
Non-cash investing and financing activities:
Issuance of Series B preferred stock for settlement of accrued dividends	279,380	261,084
Cashless exercise of warrants into common stock		9,734
Warrants issued as debt discount in connection with notes payable	36,000	315,300
Accrual of contractual dividends on Series B convertible preferred stock	149,459	139,680
Deemed dividends on Series B convertible preferred stock		1,532,722
Common stock and warrants issued in exchange of notes and accounts payable		3,625,900
Conversion of accounts payable to notes payable		$ 40,000